Allspring Global Investments Holdings LLC bought a new position in shares of AMERISAFE, Inc. (NASDAQ:AMSF - Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 9,691 shares of the insurance provider's stock, valued at approximately $509,000. Allspring Global Investments Holdings LLC owned about 0.05% of AMERISAFE at the end of the most recent quarter.
Other institutional investors and hedge funds have also bought and sold shares of the company. Mirae Asset Global Investments Co. Ltd. lifted its stake in AMERISAFE by 12.5% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 15,524 shares of the insurance provider's stock valued at $818,000 after acquiring an additional 1,731 shares during the period. Deutsche Bank AG increased its holdings in shares of AMERISAFE by 52.0% during the 4th quarter. Deutsche Bank AG now owns 18,610 shares of the insurance provider's stock valued at $959,000 after purchasing an additional 6,366 shares in the last quarter. Nuveen Asset Management LLC increased its holdings in shares of AMERISAFE by 92.1% during the 4th quarter. Nuveen Asset Management LLC now owns 161,815 shares of the insurance provider's stock valued at $8,340,000 after purchasing an additional 77,582 shares in the last quarter. Franklin Resources Inc. purchased a new position in shares of AMERISAFE during the 4th quarter valued at approximately $359,000. Finally, Ameriprise Financial Inc. increased its holdings in shares of AMERISAFE by 7.8% during the 4th quarter. Ameriprise Financial Inc. now owns 102,843 shares of the insurance provider's stock valued at $5,301,000 after purchasing an additional 7,399 shares in the last quarter. 97.41% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
Separately, JMP Securities reaffirmed a "market outperform" rating and set a $65.00 target price on shares of AMERISAFE in a report on Wednesday, April 30th.
Check Out Our Latest Stock Report on AMSF
AMERISAFE Stock Up 2.3%
Shares of NASDAQ:AMSF traded up $0.98 during trading on Friday, hitting $44.16. 116,759 shares of the stock traded hands, compared to its average volume of 108,603. The company has a market cap of $841.25 million, a price-to-earnings ratio of 17.81 and a beta of 0.40. The company has a fifty day moving average price of $45.50 and a two-hundred day moving average price of $48.71. AMERISAFE, Inc. has a 52-week low of $42.48 and a 52-week high of $60.24.
AMERISAFE (NASDAQ:AMSF - Get Free Report) last issued its earnings results on Tuesday, April 29th. The insurance provider reported $0.60 EPS for the quarter, beating analysts' consensus estimates of $0.59 by $0.01. The business had revenue of $83.78 million during the quarter, compared to analysts' expectations of $76.66 million. AMERISAFE had a net margin of 15.76% and a return on equity of 16.41%. On average, equities research analysts predict that AMERISAFE, Inc. will post 2.45 EPS for the current fiscal year.
AMERISAFE Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Friday, June 20th. Shareholders of record on Friday, June 13th were issued a $0.39 dividend. The ex-dividend date was Friday, June 13th. This represents a $1.56 dividend on an annualized basis and a yield of 3.53%. AMERISAFE's payout ratio is 62.90%.
AMERISAFE Profile
(
Free Report)
AMERISAFE, Inc, an insurance holding company, underwrites workers' compensation insurance in the United States. The company provides benefits to injured employees for temporary or permanent disability, death, and medical and hospital expenses. It sells its products through retail and wholesale brokers and agents; and small and mid-sized employers engaged in hazardous industries, including construction, trucking, logging and lumber, agriculture, manufacturing, telecommunications, and maritime.
Featured Stories

Before you consider AMERISAFE, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMERISAFE wasn't on the list.
While AMERISAFE currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.